Taiyen Biotech , Ltd. Overview
Latest PEG ratio for Taiyen Biotech , Ltd.: -178.37 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-178.37
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Taiyen Biotech , Ltd. (1737.TW) currently reports a PEG ratio of -178.37. That is below the sector sector average of 10.05. Use the charts on this page to explore Taiyen Biotech , Ltd.'s PEG ratio history and peer comparisons.
Taiyen Biotech , Ltd.'s PEG ratio of -178.37 is lower than the its sector sector average of 10.05. That is roughly 1873.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Taiyen Biotech , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At -178.37, 1737.TW can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -178.37, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.05. From there, open related valuation or income-statement pages for Taiyen Biotech , Ltd., and consider following 1737.TW for alerts when major investors trade the stock.
